Amkay Products Ltd Stock Price Today (NSE: AMKAY)
Fundamental Score
Amkay Products Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amkay Products Ltd share price today is ₹47.99, up +0.00% on NSE/BSE as of 7 August 2026. Amkay Products Ltd (AMKAY) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹43.97 (Cr). The 52-week high for AMKAY share price is ₹81.99 and the 52-week low is ₹39.22. At a P/E ratio of 19.04x, AMKAY is currently trading below its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 9.16% and a debt-to-equity ratio of 0.15.
Amkay Products Ltd Share Price Chart — NSE/BSE Historical Performance
Amkay Products Ltd share price chart: -12.67% return over the past month. 52-week high ₹81.99, 52-week low ₹39.22.
Amkay Products Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 0.00 (Cr) | |
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 0.00 (Cr) | |
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 0.00 (Cr) | |
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 4.00K (Cr) | |
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 0.00 (Cr) | |
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | 0.00 (Cr) | |
| ₹48.00 | ₹48.00 | ₹47.99 | ₹47.99 | 6.00K (Cr) | |
| ₹50.00 | ₹50.00 | ₹50.00 | ₹50.00 | 0.00 (Cr) | |
| ₹50.00 | ₹50.00 | ₹50.00 | ₹50.00 | 0.00 (Cr) | |
| ₹50.00 | ₹50.00 | ₹50.00 | ₹50.00 | 0.00 (Cr) |
Amkay Products Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹47.99 | ₹47.99 | ₹47.99 | ₹47.99 | +0.00% | |
| ₹52.61 | ₹52.61 | ₹47.30 | ₹47.99 | -8.78% | |
| ₹55.50 | ₹58.00 | ₹52.00 | ₹54.95 | -0.99% | |
| ₹57.00 | ₹63.00 | ₹54.00 | ₹57.45 | +0.79% | |
| ₹57.20 | ₹62.90 | ₹55.55 | ₹55.55 | -2.88% | |
| ₹59.66 | ₹59.66 | ₹52.00 | ₹52.00 | -12.84% | |
| ₹65.50 | ₹65.50 | ₹55.10 | ₹62.80 | -4.12% | |
| ₹58.70 | ₹79.85 | ₹56.00 | ₹68.47 | +16.64% | |
| ₹45.10 | ₹81.99 | ₹44.85 | ₹61.75 | +36.92% | |
| ₹50.00 | ₹50.00 | ₹46.00 | ₹46.00 | -8.00% | |
| ₹45.51 | ₹46.98 | ₹39.22 | ₹46.98 | +3.23% | |
| ₹51.78 | ₹54.00 | ₹47.01 | ₹47.01 | -9.21% |
AI Research Briefing
Powered by Gemini · 2026-08-01
Avoid this illiquid micro-cap disposable seller until negative cash flows turn positive and earnings growth stabilizes.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Amkay Products reported a weak FY26 performance with full-year revenue at ₹42.03 Cr and PAT declining 30.8% YoY to ₹2.31 Cr. Latest quarterly net profit plunged 77.5% YoY, reflecting severe margin pressure. No fresh material contracts, institutional disclosures, or strategic acquisitions were reported in recent weeks.
CORE STORY (THE REAL GAME)
A low-margin SME healthcare disposable assembler struggling with scale, lacking proprietary medtech IP or pricing power to capture high-value hospital procurement.
- No major catalysts found after live search in recent weeks
- Latest quarterly profit down 77.5% YoY showing sharp margin contraction
- 6-month price performance down 32.8% reflecting sustained selling pressure
- Winning large government medical device tenders or institutional supply orders
- Margin recovery through shift to higher-margin diagnostic products
- Any surge in retail trading liquidity or promoter buying
- Severe Micro/SME cap illiquidity risk with low daily traded volumes
- Negative 5-year Free Cash Flow of -₹7.0 Cr showing poor earnings quality
- Zero institutional holding (0% FII, 0% DII) leaving no floor on sell-offs
Promoter holds 73.44% with zero change (Δ 0.0%). FII and DII participation is zero (0.0%), confirming institutional complete disinterest.
India medtech sector is growing via government hospital capex, but unbranded SME disposable assemblers face margin erosion from rising input costs.
No - 5-year Free Cash Flow is negative ₹7.0 Cr against positive reported profits.
Subdued short-term outlook driven by margin headwinds and lack of fresh business catalysts.
Primary Thesis Risk
Negative cash flow conversion and continuing margin compression rendering earnings unsustained.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amkay Products Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amkay Products Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMKAY across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 19.04 vs Industry: 36.70)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.15)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.47x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.44%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (9.16%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Profit Decline Concern (-77.48%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-7.45%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (0.68% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-69.67% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-4.31% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-7.00 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amkay Products Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Amkay Products Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amkay Products LtdAmkay Products ...Selected✓ AMKAY • 544169 | 26.9/100 | ₹47.99₹48 | ₹43.97₹43.97 | 19.04Average 19.0 Average | 9.16%Poor 9.16% Poor | 12.77%Average 12.77% Average | 0.15Excellent 0.1 Excellent | -4.31%Poor -4.31% Poor | 0.68%Average 0.68% Average | 0.00% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Fischer Medical Ventures Ltd share price2522.43 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
Amkay Products Ltd PE Ratio History
Historical price-to-earnings ratio for AMKAY — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹3.04 | ₹62.66 | 20.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Amkay Products Ltd Quarterly Performance
Latest quarterly metrics for AMKAY — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-7.45%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-77.48%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
0.68%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-4.31%
Compounded annual net profit growth over 5 years
Amkay Products Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMKAY — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amkay Products Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Amkay Products Ltd (AMKAY) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Amkay Products Ltd
About AMKAY (Amkay Products Ltd)
Amkay Products Ltd is a dynamic player in the Indian medical equipment and supplies market, dedicated to enhancing healthcare accessibility and quality through its diverse product ...offerings. The company strategically focuses on manufacturing, assembling, and distributing essential medical devices and consumables that cater to a wide range of healthcare needs. From diagnostic tools to personal protective equipment, Amkay strives to provide reliable and cost-effective solutions for both healthcare professionals and individual consumers. With a commitment to innovation and quality assurance, Amkay Products Ltd aims to be a trusted partner in supporting a healthier India. Amkay Products boasts a comprehensive catalogue designed to meet the diverse demands of the modern healthcare landscape. Their product range encompasses items crucial for infection control, such as a variety of masks, sterilization materials, and protective apparel. Moreover, Amkay offers an array of diagnostic and monitoring equipment, empowering healthcare providers with the tools necessary for accurate assessments and patient care. The company also addresses the needs of home healthcare, providing products that enable individuals to manage their health conditions effectively in the comfort of their own homes. By consistently expanding and refining its offerings, Amkay Products Ltd strives to remain at the forefront of the medical supply industry. Driven by a vision of improving healthcare outcomes across India, Amkay Products Ltd emphasizes ethical business practices and a customer-centric approach. They maintain a strong focus on quality control throughout their manufacturing processes to ensure that all products meet stringent regulatory standards. Amkay's distribution network is strategically designed to reach a broad customer base, enabling them to deliver essential medical supplies efficiently and reliably. Through ongoing research and development, Amkay Products Ltd is committed to introducing innovative solutions that address emerging healthcare challenges and contribute to the overall well-being of the Indian population.
Company Details
Key Leadership
Latest News
AMKAY Share Price: Frequently Asked Questions
What is the current share price of Amkay Products Ltd?
Amkay Products Ltd (AMKAY) trades at ₹47.99 on NSE and BSE. Market cap ₹43.97 (Cr). Educational data only.
What is the P/E ratio of Amkay Products Ltd?
Amkay Products Ltd has a P/E of 19.04x vs industry average 36.70x.
What is the Bull Run score for Amkay Products Ltd?
Amkay Products Ltd has a Bull Run score of 26.9/100 based on 25+ financial parameters.
Does Amkay Products Ltd pay dividends?
Amkay Products Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Amkay Products Ltd?
Amkay Products Ltd has ROE of 9.16%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amkay Products Ltd?
Amkay Products Ltd has debt-to-equity of 0.15.
Is Amkay Products Ltd a good investment?
Bull Run gives Amkay Products Ltd a score of 26.9/100. This is not investment advice — consult a SEBI-registered advisor.